BDSX's logo.
Ticker Symbol: BDSX

Biodesix Inc

$6.69 - 15-07-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001439725

Company Profile

biodesix develops and commercializes blood-based molecular diagnostic tests that advance the standard of care in oncology. our diagnostics help patients and their doctors make more informed decisions about treatment based on a patient's unique molecular profile. we're advancing precision medicine by helping physicians provide the right patient with the right treatment at the right time, and move patients to optimal treatment faster. we partner with pharmaceutical companies to develop tests that accelerate pipelines and bring effective therapies to market. our two commercialized tests, veristrat® & genestrat™, offer results in 72 hours. no tissue is required.

Sector: Health Care and Social Assistance
Industry: Diagnostic Imaging Centers
Standard Industrial Classification Code (SIC code): 8071
Address: N/A
Website: biodesix.com
CEO: N/A
Tags:
  • Health Services
  • Medical/Nursing Services
  • Manufacturing
  • Dental Laboratories

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $1.71
Change: $0.01 ( 0.59%)
Days Range: $1.65 - $1.72
Beta: 1.20
52wk. High: $2.52
52wk. Low: $0.95
Ytd. Change -25.06%
50 Day Moving Average: $1.57
200 Day Moving Average: $1.47
Shares Outstanding: 78614114

Valuation

Market Cap: 13.4B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A